Patents by Inventor Gurdish Kaur Bhatti

Gurdish Kaur Bhatti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120070496
    Abstract: A dosage form having sustained-release or controlled-release properties for delivering 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol from the dosage form over an extended period of time in a therapeutically responsive dose to produce antidepressant therapy.
    Type: Application
    Filed: November 23, 2011
    Publication date: March 22, 2012
    Applicant: Alza Corporation
    Inventors: David Emil Edgren, Gurdish Kaur Bhatti, Zahedeh Hatamkhani, Patrick S.-L. Wong
  • Patent number: 8084059
    Abstract: The invention pertains to a dosage form 10 and to administering an antidepressant medicament 16 for an extended period of time in a rate-known dose.
    Type: Grant
    Filed: September 15, 2006
    Date of Patent: December 27, 2011
    Assignee: ALZA Corporation
    Inventors: David Emil Edgren, Gurdish Kaur Bhatti, Zahedeh Hatamkhani, Patrick S. L. Wong
  • Publication number: 20100260810
    Abstract: The invention pertains to a dosage form 10 and to administering an antidepressant medicament 16 for an extended period of time in a rate-known dose.
    Type: Application
    Filed: June 22, 2010
    Publication date: October 14, 2010
    Inventors: David Emil Edgren, Gurdish Kaur Bhatti, Zahedeh Hatamkhani, Patrick S.-L. Wong
  • Publication number: 20040092601
    Abstract: The invention pertains to a dosage form 10 and to administering an antidepressant medicament 16 for an extended period of time in a rate-known dose.
    Type: Application
    Filed: October 28, 2003
    Publication date: May 13, 2004
    Inventors: David Emil Edgren, Gurdish Kaur Bhatti, Zahedeh Hatamkhani, Patrick S.L. Wong
  • Publication number: 20040086570
    Abstract: The invention pertains to a dosage form 10 and to administering an antidepressant medicament 16 for an extended period of time in a rate-known dose.
    Type: Application
    Filed: October 28, 2003
    Publication date: May 6, 2004
    Inventors: David Emil Edgren, Gurdish Kaur Bhatti, Zahedeh Hatamkhani, Patrick S.L. Wong
  • Patent number: 6440457
    Abstract: The invention pertains to a dosage form 10 and to administering an antidepressant medicament 16 for an extended period of time in a rate-known dose.
    Type: Grant
    Filed: May 27, 1993
    Date of Patent: August 27, 2002
    Assignee: Alza Corporation
    Inventors: David Emil Edgren, Gurdish Kaur Bhatti, Zahedeh Hatamkhani, Patrick S. L. Wong
  • Patent number: 6245357
    Abstract: A dosage form comprising a composition comprising a drug surrounded by an interior and an exterior wall with an exit for administering the drug to a patient; and a method of using the dosage form are disclosed for an indicated therapy.
    Type: Grant
    Filed: February 12, 1999
    Date of Patent: June 12, 2001
    Assignee: Alza Corporation
    Inventors: David E. Edgren, Shu Li, Gurdish Kaur Bhatti, Patrick S. L. Wong, Robert R. Skluzacek
  • Patent number: 5718700
    Abstract: A dosage form is disclosed comprising a wall that surrounds a bilayer core with exit passageway for communicating with the bilayer core in the wall.
    Type: Grant
    Filed: September 20, 1994
    Date of Patent: February 17, 1998
    Assignee: ALZA Corporation
    Inventors: David Emil Edgren, Robert Raymond Skluzacek, Brian L. Barclay, Gurdish Kaur Bhatti